As of Jan 20
| -0.01 / -0.82%|
The 2 analysts offering 12-month price forecasts for CASI Pharmaceuticals Inc have a median target of 3.50, with a high estimate of 4.00 and a low estimate of 3.00. The median estimate represents a +189.26% increase from the last price of 1.21.
The current consensus among 2 polled investment analysts is to Buy stock in CASI Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.